Traditional cardiovascular risk factors combine, in the context of inflammatory rheumatic diseases, with disease-related and treatment-related risk factors, to determine a patient's overall risk of cardiovascular disease (CVD). These competing risks are explored in this Review, which summarizes why CVD risk is increased in these patients, and what remains to understand before patients can be offered the best advice about CVD risk management.
- Deborah P. M. Symmons
- Sherine E. Gabriel